CRC
IART icon

Curi RMB Capital’s Integra LifeSciences IART Stock Holding History

Curi RMB Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-100,299
Closed -$5.06M – 925
2017
Q3 		$5.06M Hold
100,299
– – 0.13% 231
2017
Q2 		$5.47M Buy
+100,299
New +$4.79M 0.16% 202

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Curi RMB Capital's IART Position: Q4 2017 in Review

Curi RMB Capital sold out of Integra LifeSciences (IART) in Q4 2017, closing a stake of 100,299 shares — an estimated $5.06M sold.

Curi RMB Capital first reported a position in IART in Q2 2017 and held it in 2 quarters. The position peaked at $5.47M in Q2 2017. 221 funds tracked by Wall St. Rank hold IART as of Q4 2017.

  • Curi RMB Capital reported no remaining Integra LifeSciences position as of Q4 2017 after selling out during the quarter.
  • Curi RMB Capital sold 100,299 Integra LifeSciences shares in Q4 2017, an estimated $5.06M.
  • Curi RMB Capital first reported a position in Integra LifeSciences in Q2 2017 and held it in 2 quarters.
  • Curi RMB Capital's Integra LifeSciences position peaked at $5.47M in Q2 2017.
  • 221 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2017.

Based on Curi RMB Capital's 13F filing for Q4 2017, filed 14 Feb 2018.